Three-weekly docetaxel with prednisone is feasible for Japanese patients with hormone-refractory prostate cancer: a retrospective comparative study with weekly docetaxel alone.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples